Print

Lay Description

This will be a long-term multi-center study to comprehensively study patients with primary liver cancer (PLC).

Category

  • Cancers and Other Neoplasms
IRB Number
STUDY00000023
NCT Number
NCT # not yet entered

Eligibility

Eligible Ages
18 and Up
Eligible Genders
All
Accepts Healthy Volunteers

Inclusion Criteria

Patients with histologically/ultrasound/imaging confirmed or suspicious lesions of HCC or CCA.

Patients with planned or a history of at least 1 dose of immunotherapy for HCC or CCA.

Ability of subject to understand and the willingness to sign a written informed consent document.

Age > 18 years old at date of study consent

Exclusion Criteria

Patients with known HIV infection as these patients may have abnormal test results which may confound the endpoints of this study

Study Design

Arm Groups

Study Contact

Frances Crawford
210-450-5037
crawfordf1@uthscsa.edu

Myrna Montenegro
210-450-5954
montenegro@uthscsa.edu

Kathleen Rodriguez
210-450-1365
rodriguezk3@uthscsa.edu

Benjamin Schleif
210-450-1366
schleifb@uthscsa.edu

Morgan Seekatz
210-450-1133
seekatz@uthscsa.edu

Jessica Villarreal

villarreal24@uthscsa.edu

Epp Goodwin
210-450-5798
goodwine@uthscsa.edu

Principal Investigator
Sukeshi Arora